vs
Side-by-side financial comparison of BV Financial, Inc. (BVFL) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $10.5M, roughly 1.3× BV Financial, Inc.). BV Financial, Inc. runs the higher net margin — 45.6% vs -73.9%, a 119.4% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 9.2%). BV Financial, Inc. produced more free cash flow last quarter ($18.8M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 11.1%).
Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
BVFL vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.5M | $13.2M |
| Net Profit | $4.8M | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | 66.9% | -24.8% |
| Net Margin | 45.6% | -73.9% |
| Revenue YoY | 9.2% | 59.8% |
| Net Profit YoY | 146.2% | 3.5% |
| EPS (diluted) | $0.52 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $10.5M | $13.2M | ||
| Q3 25 | $10.0M | $11.6M | ||
| Q2 25 | $9.9M | $11.2M | ||
| Q1 25 | $9.2M | $9.2M | ||
| Q4 24 | $9.7M | $8.3M | ||
| Q3 24 | $10.0M | $7.3M | ||
| Q2 24 | $9.5M | $7.4M | ||
| Q1 24 | $8.5M | $6.5M |
| Q4 25 | $4.8M | $-9.8M | ||
| Q3 25 | $3.7M | $-10.8M | ||
| Q2 25 | $2.9M | $-8.3M | ||
| Q1 25 | $2.1M | $-10.4M | ||
| Q4 24 | $2.0M | $-10.1M | ||
| Q3 24 | $3.8M | $-2.4M | ||
| Q2 24 | $3.4M | $-4.3M | ||
| Q1 24 | $2.6M | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | 66.9% | -24.8% | ||
| Q3 25 | 51.5% | -77.9% | ||
| Q2 25 | 39.9% | -65.4% | ||
| Q1 25 | 29.4% | -79.9% | ||
| Q4 24 | 29.5% | -91.8% | ||
| Q3 24 | 52.4% | -118.9% | ||
| Q2 24 | 49.6% | -111.0% | ||
| Q1 24 | 42.1% | -180.8% |
| Q4 25 | 45.6% | -73.9% | ||
| Q3 25 | 37.2% | -93.5% | ||
| Q2 25 | 29.0% | -73.9% | ||
| Q1 25 | 22.9% | -113.2% | ||
| Q4 24 | 20.2% | -122.4% | ||
| Q3 24 | 38.0% | -32.6% | ||
| Q2 24 | 35.8% | -58.8% | ||
| Q1 24 | 30.1% | -204.5% |
| Q4 25 | $0.52 | $-0.22 | ||
| Q3 25 | $0.41 | $-0.96 | ||
| Q2 25 | $0.29 | $-0.27 | ||
| Q1 25 | $0.21 | $-0.39 | ||
| Q4 24 | $0.18 | $-0.38 | ||
| Q3 24 | $0.35 | $-0.12 | ||
| Q2 24 | $0.32 | $-0.21 | ||
| Q1 24 | $0.24 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $55.7M | $20.4M |
| Total DebtLower is stronger | $35.0M | — |
| Stockholders' EquityBook value | $183.8M | $-33.9M |
| Total Assets | $912.2M | $35.3M |
| Debt / EquityLower = less leverage | 0.19× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.7M | $20.4M | ||
| Q3 25 | $63.5M | $22.7M | ||
| Q2 25 | $56.3M | $26.5M | ||
| Q1 25 | $70.8M | $13.0M | ||
| Q4 24 | $70.5M | $8.5M | ||
| Q3 24 | $94.1M | $11.3M | ||
| Q2 24 | $90.6M | $16.5M | ||
| Q1 24 | $78.8M | $4.0M |
| Q4 25 | $35.0M | — | ||
| Q3 25 | $35.0M | — | ||
| Q2 25 | $35.0M | — | ||
| Q1 25 | $49.9M | — | ||
| Q4 24 | $49.9M | — | ||
| Q3 24 | $34.8M | — | ||
| Q2 24 | $34.8M | — | ||
| Q1 24 | $34.8M | — |
| Q4 25 | $183.8M | $-33.9M | ||
| Q3 25 | $190.2M | $-26.7M | ||
| Q2 25 | $198.0M | $-19.4M | ||
| Q1 25 | $198.1M | $-34.4M | ||
| Q4 24 | $195.5M | $-25.9M | ||
| Q3 24 | $209.7M | $-20.4M | ||
| Q2 24 | $205.5M | $-25.3M | ||
| Q1 24 | $201.8M | $-36.0M |
| Q4 25 | $912.2M | $35.3M | ||
| Q3 25 | $909.4M | $36.5M | ||
| Q2 25 | $908.3M | $41.3M | ||
| Q1 25 | $921.9M | $28.6M | ||
| Q4 24 | $911.8M | $24.0M | ||
| Q3 24 | $892.7M | $27.5M | ||
| Q2 24 | $897.2M | $32.4M | ||
| Q1 24 | $892.5M | $17.9M |
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.18× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 0.26× | — | ||
| Q3 24 | 0.17× | — | ||
| Q2 24 | 0.17× | — | ||
| Q1 24 | 0.17× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.0M | $-2.5M |
| Free Cash FlowOCF − Capex | $18.8M | $-2.5M |
| FCF MarginFCF / Revenue | 178.2% | -19.1% |
| Capex IntensityCapex / Revenue | 2.2% | 0.3% |
| Cash ConversionOCF / Net Profit | 3.96× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.0M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.0M | $-2.5M | ||
| Q3 25 | $8.4M | $-3.7M | ||
| Q2 25 | $2.7M | $-7.3M | ||
| Q1 25 | $4.4M | $-4.5M | ||
| Q4 24 | $16.1M | $-5.7M | ||
| Q3 24 | $6.1M | $-10.8M | ||
| Q2 24 | $1.5M | $-13.4M | ||
| Q1 24 | $4.6M | $-10.9M |
| Q4 25 | $18.8M | $-2.5M | ||
| Q3 25 | $8.4M | $-3.9M | ||
| Q2 25 | $2.6M | $-7.4M | ||
| Q1 25 | $4.2M | $-5.3M | ||
| Q4 24 | $15.5M | $-5.8M | ||
| Q3 24 | $6.0M | $-11.0M | ||
| Q2 24 | $1.4M | $-13.5M | ||
| Q1 24 | $4.1M | $-10.9M |
| Q4 25 | 178.2% | -19.1% | ||
| Q3 25 | 84.0% | -33.9% | ||
| Q2 25 | 26.1% | -66.1% | ||
| Q1 25 | 46.0% | -57.3% | ||
| Q4 24 | 160.0% | -69.7% | ||
| Q3 24 | 59.6% | -149.9% | ||
| Q2 24 | 15.2% | -183.1% | ||
| Q1 24 | 48.4% | -169.3% |
| Q4 25 | 2.2% | 0.3% | ||
| Q3 25 | 0.1% | 1.9% | ||
| Q2 25 | 1.4% | 0.8% | ||
| Q1 25 | 2.4% | 8.2% | ||
| Q4 24 | 6.3% | 0.6% | ||
| Q3 24 | 1.0% | 2.3% | ||
| Q2 24 | 0.6% | 0.8% | ||
| Q1 24 | 5.1% | 1.0% |
| Q4 25 | 3.96× | — | ||
| Q3 25 | 2.26× | — | ||
| Q2 25 | 0.95× | — | ||
| Q1 25 | 2.11× | — | ||
| Q4 24 | 8.23× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 0.44× | — | ||
| Q1 24 | 1.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
